Memory Pharmaceuticals to Present at UBS Global Life Sciences Conference
Montvale, NJ - September 19, 2005 - Memory Pharmaceuticals Corp. (NASDAQ: MEMY) today announced that Jim Sulat, President and Chief Executive Officer, will provide a Company update at the UBS Global Life Sciences Conference on September 26th at 12:30 p.m. EDT, at the Grand Hyatt Hotel in New York.
Interested parties may access a live audio webcast of the presentation by visiting the Investor Relations section of Memory Pharmaceuticals' website at http://www.memorypharma.com. An archived version of the webcast will be available at the same location through October 2, 2005.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression, vascular dementia, mild cognitive impairment, Parkinson's disease and memory impairments associated with aging. For additional information, please visit our website at http://www.memorypharma.com.